Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-08

Clinical Trial Update: Drug-Drug Interaction Study Between Telaprevir and Buprenorphine [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study between telaprevir and buprenorphine has been completed, evaluating safety and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telaprevir (telaprevir)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Hepatitis C, Opioid-Related Disorders | Phase 1 | Status: COMPLETED